Personal View: Low-Dose Lung Radiotherapy Should be Evaluated as a Treatment for Severe COVID-19 Lung Disease.

Hadjiyiannakis, D; Dimitroyannis, D; Eastlake, L; Peedell, C; Tripathi, L; Simcock, R; Vyas, A; Deutsch, E; Chalmers, A J.

Afiliação

Hadjiyiannakis D; Lancashire Teaching Hospitals, NHS Foundation Trust, Preston, UK; NIHR Lancashire Clinical Research Facility, Preston, UK.
Dimitroyannis D; Edward Hines Jr, VA Hospital, Hines, Illinois, USA.
Eastlake L; University Hospitals Plymouth NHS Trust, Plymouth, UK. Electronic address: leonie.eastlake@nhs.net.
Peedell C; James Cook University Hospital, Middlesbrough, UK.
Tripathi L; Lancashire Teaching Hospitals, NHS Foundation Trust, Preston, UK; NIHR Lancashire Clinical Research Facility, Preston, UK.
Simcock R; Brighton and Sussex University Hospitals NHS Trust, Brighton, UK.
Vyas A; Lancashire Teaching Hospitals, NHS Foundation Trust, Preston, UK.
Deutsch E; Radiation Oncology Department, Gustave Roussy Cancer Campus, Université Paris, Villejuif, France.
Chalmers AJ; Institute of Cancer Sciences, University of Glasgow, Glasgow, UK.

Clin Oncol (R Coll Radiol) ; 33(1): e64-e68, 2021 Jan.

Article em En | MEDLINE | ID: mdl-32829986

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2021 Tipo de documento: Article